SMOX and cystic fibrosis: Second, we investigated PAO1 and PAO1 ΔmexZ in a flow-cell biofilm system developed for pharmaco-kinetic and -dynamic investigations with dosing of antibiotics according to the treatment regimes of CF patients in the clinic.